Literature DB >> 5209

Vasodilator administration in the presence of beta-adrenergic blockade.

W J Mroczek, W R Lee, M E Davidov, F A Finnerty.   

Abstract

To explore the possibility that the presence of propranolol-induced beta-adrenergic blockade might have an adverse effect upon homeostatic circulatory reflexes activated by the administration of a potent vasodilator agent, arterial blood pressure and pulse rate response to rapid intravenous diazoxide injection was monitored before and after pretreatment with propranolol in ten hypertensive patients. It appeared that beta-adrenergic blockade had no clinically significant effect on the magnitude of hypotension or the degree of heart rate acceleration induced by the administration of the potent vasodilator diazoxide. This reflex vasodilator-induced cardio-acceleration after propranolol adminstration could be the result of incomplete blockade of endogenously released neurotransmitter, inhibition of the parasympathetic nervous system, or a direct pharmacologic action of diazoxide. Diazoxide administration to hypertensive patients in the presence of beta-adrenergic blockade was not associated with any clinically significant hemodynamic consequences.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5209     DOI: 10.1161/01.cir.53.6.985

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Management of more severe cases of hypertension.

Authors:  H Mandin
Journal:  Can Fam Physician       Date:  1985-02       Impact factor: 3.275

2.  Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

3.  Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension.

Authors:  A J Man in 't Veld; G J Wenting; F Boomsma; R P Verhoeven; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

4.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

5.  Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.

Authors:  L R Krusell; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.